Multidisciplinary specialists, social workers and palliative care providers are valuable contributors
Studies investigate two potential risk-prediction methods
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Team prevents amputation and leaves femoral head intact
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Why it remains the mainstay for newly diagnosed metastases and tumors
Study reports on 11-year experience in AML
Apical-height dosing produces outcomes comparable to 5-mm dosing
Current trials study novel therapies for rhabdomyosarcoma and clear cell sarcoma
Produces favorable oncologic outcomes, wound healing and quality of life
Inhibition of DNA-PK suppresses tumor growth in preclinical models
Advertisement
Advertisement